{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20150729",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "43532",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/207071Orig1s000TOC.html",
              "date": "20160413",
              "type": "Review"
            },
            {
              "id": "44955",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/207071Orig1s000SumR.pdf",
              "date": "20160413",
              "type": "Summary Review"
            },
            {
              "id": "19956",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207071s000lbl.pdf",
              "date": "20150804",
              "type": "Label"
            },
            {
              "id": "32843",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/207071Orig1s000ltr.pdf",
              "date": "20150731",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20201201",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "65455",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207071s002s004lbl.pdf",
              "date": "20201201",
              "type": "Label"
            },
            {
              "id": "65462",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/207071Orig1s002,s004ltr.pdf",
              "date": "20201202",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20201201",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "65454",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207071s002s004lbl.pdf",
              "date": "20201201",
              "type": "Label"
            },
            {
              "id": "65461",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/207071Orig1s002,s004ltr.pdf",
              "date": "20201202",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA207071",
      "sponsor_name": "LEO PHARMA AS",
      "openfda": {
        "application_number": [
          "NDA207071"
        ],
        "brand_name": [
          "FINACEA FOAM"
        ],
        "generic_name": [
          "AZELAIC ACID"
        ],
        "manufacturer_name": [
          "LEO Pharma Inc."
        ],
        "product_ndc": [
          "50222-303"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "TOPICAL"
        ],
        "substance_name": [
          "AZELAIC ACID"
        ],
        "rxcui": [
          "1659800",
          "1659803"
        ],
        "spl_id": [
          "f51a0452-513f-488f-b0f9-b723cf96bdf7"
        ],
        "spl_set_id": [
          "9fabd24e-4c3b-49a0-aa5f-c8d75ae67572"
        ],
        "package_ndc": [
          "50222-303-50",
          "50222-303-91"
        ],
        "nui": [
          "N0000008841",
          "N0000009982"
        ],
        "pharm_class_pe": [
          "Decreased Protein Synthesis [PE]",
          "Decreased Sebaceous Gland Activity [PE]"
        ],
        "unii": [
          "F2VW3D43YT"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "FINACEA",
          "active_ingredients": [
            {
              "name": "AZELAIC ACID",
              "strength": "15%"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "AEROSOL, FOAM",
          "route": "TOPICAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}